BlackRock Health Sciences Term Trust's 5% share buyback offer is oversubscribed
BMEZ•BlackRock Health Sciences Term Trust received tenders for 13,178,845 shares against 3,125,070 shares offered for repurchase. Accepted shares will be bought at 98% of net asset value, with proration expected because the offer was oversubscribed.
1. Tender offer results
Preliminary results showed that BlackRock Health Sciences Term Trust’s offer to repurchase up to 5% of its outstanding common shares drew 13,178,845 shares, compared with 3,125,070 shares offered for repurchase. The offer ran from October 16 through November 18, 2026.
2. Price and proration
Repurchases are expected to be prorated. Accepted shares will be purchased at 98% of net asset value as of the November 19, 2026, New York Stock Exchange close; final results, including the proration factor, are expected on or about that date.




